Loading company…
Eden Prairie-based Metavention develops the iRF Denervation System, a minimally invasive treatment for high blood pressure.
Founded in 2012 and headquartered in Eden Prairie, US, Metavention, Inc. develops minimally invasive treatments for high blood pressure and metabolic disease. Its iRF Denervation System uses radio frequency energy to disrupt overactive sympathetic nerves tied to kidney function. In December 2017 the company raised USD 65 mn in a Series C round led by New Enterprise Associates.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in